Clinical trial
Glutaminergic Agents for Cocaine Abuse - 5
NCT00000280 · Yale University, Other · Completed
Key facts
| NCT number | NCT00000280 |
|---|---|
| Title | Glutaminergic Agents for Cocaine Abuse - 5 |
| Official title | Glutaminergic Agents for Cocaine Abuse |
| Lead sponsor | Yale University, Other |
| Collaborators | National Institute on Drug Abuse (NIDA) NIH VA Connecticut Healthcare System U.S. Fed |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Cocaine-Related Disorders |
| Intervention type | Drug |
| Interventions | Nimodipine |
| Enrollment | 0 |
| Start date | Sep 1, 1994 |
| Primary completion | Aug 1, 1999 |
| Completion | Aug 1, 1999 |
| First posted | Sep 21, 1999 |
| Last update posted | Apr 25, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: